Related Experiment Video
Updated: Jun 2, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Neuromodulation in drug-resistant primary headaches: what have we learned?
Massimo Leone1, Alberto Proietti Cecchini, Angelo Franzini
1Headache Centre Neurology Department, National Neurological Institute (IRCCS) Foundation C.Besta, via Celoria 11, 20133 Milan, Italy. leone@istituto-besta.it
Abstract:
In the last years neurostimulation procedures have been introduced to treat primary neurovascular headaches, namely cluster headache and migraine. Hypothalamic stimulation is now accepted as therapeutic procedure to treat drug-resistant chronic cluster headache when patients suffer from daily multiple attacks. The inadequacy of the definition of the term "chronic" according to the International Headache Society criteria for both cluster headache and migraine when it is used to select patients for neurostimulation procedures is now evident. On the same side, there is no agreement about the use of the term "drug-resistant" again when it is used to select patients for neurostimulation procedures. We have proposed that only patients suffering from daily neurovascular headaches in the last 1-2 years, with complete drug-resistance should be proposed for invasive procedures.
Related Concept Videos
Analgesia and Pain Management
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Release or Uptake

